Search

Poster presentations: Epidemiology 2022

P628 Processed and ultra-processed food and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)

P629 Evolution of disease phenotype, time to biological therapy and medium-, long-term surgery rates in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort

P630 Systematic review and meta-analysis: Diagnostic delay and the subsequent impact on the disease course of adult Inflammatory Bowel Disease

P631 Impact of Covid-19 pandemic on initiation of immunosuppressive treatment in immune-mediated diseases. -A nationwide, retrospective study-

P632 Estimating indirect and out-of-pocket disease-associated costs in paediatric Inflammatory Bowel Disease: a nation-wide cross-sectional analysis

P635 Incidence, prevalence, disease phenotype and maximal therapeutic step in Ulcerative Colitis patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem County cohort

P636 Work disability after 20 years with Inflammatory Bowel Disease - results from the IBSEN study

P637 Risks of Development of COVID-19 among Patients with Inflammatory Bowel Disease

P639 Incidence and disease presentation of inflammatory bowel disease in Denmark: initial findings from a Copenhagen IBD Inception Cohort Study

P640 Incidence, prevalence, disease phenotype and maximal therapeutic step in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort

P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

P642 Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional study

P643 Generalizability of Crohn’s disease randomized controlled trials compared to clinical practice

P644 Impact of Postoperative Treatment with Immunomodulators and Anti-TNFα agents on long-term Reoperation Rate in ileocaecal Crohn’s Disease.

P645 Ileocecal resection in paediatric Crohn’s disease based on the Hungarian Paediatric IBD Registry

P646 Will the screening of SARS-COV-2 infection in IBD infusion centers be useful?

P647 Idiopathic Thrombocytopenic Purpura associated with Inflammatory Bowel Disease: a multi-centre ECCO CONFER case series

P648 Prevalence and Impact of Alcohol Consumption and Cannabis Use on Inflammatory Bowel Diseases

P649 The impact of COVID-19 on quality of life among patients with inflammatory bowel diseases – A Danish prospective population-based cohort study

P650 IBD care from the patient perspective: The patient's turn

P652 The burden of mental illness, including deliberate self-harm, before and after a diagnosis of IBD, a UK population study.

P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark

P654 Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry.

P655 Early life mebendazole exposure increases the risk of adult-onset ulcerative colitis: a population-based cohort study

P656 The impact of periodontitis on IBD disease activity

P657 Persistence in smoking cessation in inflammatory bowel disease (IBD)

P658 Evolution of disease phenotype, time to biological therapy and medium-, long-term colectomy rates in Ulcerative Colitis patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort

P659 No decrease in number of new Inflammatory Bowel Disease diagnoses in children in the Netherlands during the Covid-19 pandemic: a nationwide retrospective cohort study

P660 Knowledge, attitudes, and awareness of contraceptive choices in women with Inflammatory Bowel Disease

P661 Pre-diagnostic vitamin D levels in Inflammatory Bowel Disease

P662 Colorectal Cancer in Patients with Ulcerative Colitis: A National Cohort Study between 1991-2020

P663 Mild COVID-19 disease and breakthrough cases among children with inflammatory bowel disease: An update from an international registry

P664 Bidirectional association between inflammatory bowel disease and psoriasis in a pediatric population: A nationwide insurance claim data analysis in South Korea.

P665 Towards FAIR longitudinal IBD registries: preliminary results of an iterative design process of a reusable and interoperable IBD database model

P666 Trend of Lower gastrointestinal Endoscopy in Patients with Inflammatory Bowel Diseases : A Nationwide Population-Based Study in South Korea

P667 Unmet needs in the management of Inflammatory Bowel Diseases in Egypt

P668 Real world use and adverse events of SARs-CoV-2 vaccination in Greek patients with Inflammatory Bowel Disease

P669 Validation of prior infliximab exposure and total colectomy outcome in patients with ulcerative colitis in Sweden

P670 Familial Inflammatory Bowel Disease is associated with a more adverse disease compared to sporadic cases

P671 Occurrence and clinical impact of eosinophilic esophagitis in a large cohort of children with Inflammatory Bowel Disease.

P672 Biologic therapy for Inflammatory Bowel Disease in Poland in 2020: nationwide data.

P673 Trends in inflammatory bowel disease infections and vaccinations in the past four decades - a high-level text mining analysis of PubMed publications.

P674 Predictors of response to biologics in Crohn's Diseases: A population-based study from the epi-IIRN

P675 Associations between Inflammatory Bowel Disease, social isolation, and mortality: evidence from UK Biobank cohort study

P676 Burden of depression and anxiety among inflammatory bowel disease patients in a national cohort in Israel – Data from the EPI-IIRN

P677 Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry

P678 Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry

P679 Inflammatory Bowel Disease and cancer risk in the IBSEN study after 30 years of follow-up.

P680 Epidemiology of Inflammatory Bowel Disease in Poland 2009-2020: nationwide data

P681 Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinoma

P682 Predictors of response to biologics in Ulcerative Colitis: A population-based study from the epi-IIRN

P683 Discontinuation of infliximab treatment: a comparison between IBD patients who retransitioned to originator and those who remained on biosimilar

P684 Increased risk of cardiovascular disease and high risk profiles compatible with metabolic syndrome in patients with Inflammatory Bowel Disease: a cross-sectional analysis of matched cohorts

P685 Strong Response to SARS-CoV-2 Vaccine Additional Doses among Patients with Inflammatory Bowel Diseases

P686 Outcomes of COVID-19 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study

P687 Prevalence of iron deficiency and anaemia in the outpatient Inflammatory Bowel Disease population: a Dutch national cross-sectional study

P688 Sex difference in inflammatory bowel disease patients regarding depression: a nationwide population based study in Korea

P689 Multicenter, cross-sectional, observational study on Epstein–Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan

P690 Rates of IBD in New Zealand Māori population at Lakes District Health Board: low but increasing

P691 Influence of ethnicity on the phenotype and clinical outcomes in Inflammatory Bowel Disease; comparison of a South American with a North American population.

P692 Clinical, therapeutic and evolutionary profile of fistulizing ano-perineal lesions in Crohn's disease

P693 Willingness and hesitancy to the telemedicine in patients with inflammatory bowel disease during COVID-19 outbreak. Preliminary results of a survey in an Italian IBD Center

P694 COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy.

P695 Attitudes and predictors of COVID-19 vaccine uptake in patients with Inflammatory Bowel Disease